Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
Clinical trial NCT04510090 · COMPLETED
Trial details
- NCT number
- NCT04510090
- Sponsor
- Escient Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2021-07-08
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.